imidafenacin, KRP-197/ONO-8025 + imidafenacin, KRP-197/ONO-8025
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Overactive Bladder
Conditions
Overactive Bladder
Trial Timeline
Aug 1, 2007 → —
NCT ID
NCT00512785About imidafenacin, KRP-197/ONO-8025 + imidafenacin, KRP-197/ONO-8025
imidafenacin, KRP-197/ONO-8025 + imidafenacin, KRP-197/ONO-8025 is a phase 3 stage product being developed by Ono Pharmaceutical for Overactive Bladder. The current trial status is completed. This product is registered under clinical trial identifier NCT00512785. Target conditions include Overactive Bladder.
What happened to similar drugs?
20 of 20 similar drugs in Overactive Bladder were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00512785 | Phase 3 | Completed |
Competing Products
20 competing products in Overactive Bladder